@misc{10902/33549,
year = {2024},
month = {6},
url = {https://hdl.handle.net/10902/33549},
abstract = {The pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver 
Dis-ease (MASLD) is multifaceted, involving an intricate interaction among 
genetic predis-position, diet, environmental factors, lifestyle choices, and the gut 
micro-biome (GM). The complexity of these interactions may explain the 
difficulties to obtain an effective pharmacological treatment for MASLD. Purpose 
of review: To explain the relevance of Fecal Microbiota Transplantation (FMT) for 
the treatment of MASLD, the scientific evi-dence supporting its usefulness, and 
the difficulties of its translation into effective treatments for use in routine clinical 
practice. Recent findings: FMT has been proven effective and safety in other 
indications and several procedures have been testing for delivery of fecal 
microbiota to the intestine. The field awaits results from ongoing clinical trials to 
better understand the role of FMT in the management of MASLD.},
title = {Evaluación del potencial terapéutico del trasplante de microbiota fecal en la enfermedad hepática esteatósica: conocimientos actuales y vías futuras},
author = {Vallejo García, Ignacio},
}